Видео ютуба по тегу Marketing Authorisation

Recent Updates: Variation to the terms of a marketing authorisation
Recent Updates: Variation to the terms of a marketing authorisation
Enter Indonesia’s $102B Cosmetic Market: BPOM Rules + Mandatory Halal Guide
Enter Indonesia’s $102B Cosmetic Market: BPOM Rules + Mandatory Halal Guide
Week11 - eCTD JNDA Submissions
Week11 - eCTD JNDA Submissions
E-cigarette Marketing and Young Adults: Understanding Appeal, Engagement, and Behavior to Guide...
E-cigarette Marketing and Young Adults: Understanding Appeal, Engagement, and Behavior to Guide...
Regulatory affairs,drug development,Drug Development/Approval Process #regulatory #regulatoryaffairs
Regulatory affairs,drug development,Drug Development/Approval Process #regulatory #regulatoryaffairs
Cytokinetics Investor Conference Call on FDA Approval of MYQORZO™ | Dec 19, 2025
Cytokinetics Investor Conference Call on FDA Approval of MYQORZO™ | Dec 19, 2025
Компания Eco Animal Health получила одобрение ЕС на препарат ECOVAXXIN® MS.
Компания Eco Animal Health получила одобрение ЕС на препарат ECOVAXXIN® MS.
FDA Gave Precigen (PGEN) a Monopoly in This Market and Competitors Are Running Out of Time
FDA Gave Precigen (PGEN) a Monopoly in This Market and Competitors Are Running Out of Time
EMA Post Authorisation Procedural Advice-Key Updates
EMA Post Authorisation Procedural Advice-Key Updates
Message from the Secretary-cum-Scientific Director, IPC for all Market Authorization Holders (MAHs)
Message from the Secretary-cum-Scientific Director, IPC for all Market Authorization Holders (MAHs)
Application of the cGBT+MD for Regulatory Reliance and Marketing Authorization of Medical Devices
Application of the cGBT+MD for Regulatory Reliance and Marketing Authorization of Medical Devices
Application of the cGBT+MD for Post-Market Surveillance and Market Oversight of Medical Devices
Application of the cGBT+MD for Post-Market Surveillance and Market Oversight of Medical Devices
Whitepaper: Procedural and regulatory know how for China biotech in the EU
Whitepaper: Procedural and regulatory know how for China biotech in the EU
The Transforming Health Series: Where market access meets patient access
The Transforming Health Series: Where market access meets patient access
Orphan Drugs Market Challenges and EU Regulation
Orphan Drugs Market Challenges and EU Regulation
Russia-China Pharmaceutical Market Prospects
Russia-China Pharmaceutical Market Prospects
АУКАТЗИЛ®: новая надежда для взрослых пациентов с рецидивирующим/рецидивирующим лейкозом
АУКАТЗИЛ®: новая надежда для взрослых пациентов с рецидивирующим/рецидивирующим лейкозом
New Drug Approval Roadmap According to CDSCO
New Drug Approval Roadmap According to CDSCO
The Essential Role of the EU QPPV in Pharmacovigilance
The Essential Role of the EU QPPV in Pharmacovigilance
China Pharma Market Innovation Regulation and Global Impact
China Pharma Market Innovation Regulation and Global Impact
Strategies for FDA Premarket Approval (PMA) success
Strategies for FDA Premarket Approval (PMA) success
Inside Anavex’s EMA (and FDA) Strategy: Approval Imminent?
Inside Anavex’s EMA (and FDA) Strategy: Approval Imminent?
Demystifying Pharmacovigilance Requirements in Kenya - PPB Notice on QPPV Nominations
Demystifying Pharmacovigilance Requirements in Kenya - PPB Notice on QPPV Nominations
FDA Recalls Omama Herbal Mixture: Adulterated with Prescription Drugs
FDA Recalls Omama Herbal Mixture: Adulterated with Prescription Drugs
FDA Bans Omama Herbal Mixture: Hidden Prescription Drugs Revealed!
FDA Bans Omama Herbal Mixture: Hidden Prescription Drugs Revealed!